Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says

The CDC analysis suggests the shots will reduce the burden of RSV on hospitals in the fall.

Previous post Flavored e-cigarette sales are booming despite federal crackdown
Next post : Dow’s stock falls after BofA recommends selling, given demand recovery remains elusive